Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
1.
Neuroscience Bulletin ; (6): 241-254, 2024.
Article in English | WPRIM | ID: wpr-1010671

ABSTRACT

The accumulation and spread of prion-like proteins is a key feature of neurodegenerative diseases (NDs) such as Alzheimer's disease, Parkinson's disease, or Amyotrophic Lateral Sclerosis. In a process known as 'seeding', prion-like proteins such as amyloid beta, microtubule-associated protein tau, α-synuclein, silence superoxide dismutase 1, or transactive response DNA-binding protein 43 kDa, propagate their misfolded conformations by transforming their respective soluble monomers into fibrils. Cellular and molecular evidence of prion-like propagation in NDs, the clinical relevance of their 'seeding' capacities, and their levels of contribution towards disease progression have been intensively studied over recent years. This review unpacks the cyclic prion-like propagation in cells including factors of aggregate internalization, endo-lysosomal leaking, aggregate degradation, and secretion. Debates on the importance of the role of prion-like protein aggregates in NDs, whether causal or consequent, are also discussed. Applications lead to a greater understanding of ND pathogenesis and increased potential for therapeutic strategies.


Subject(s)
Humans , Prions , Neurodegenerative Diseases/pathology , Amyloid beta-Peptides , Alzheimer Disease , alpha-Synuclein , tau Proteins , Parkinson Disease
2.
Neuroscience Bulletin ; (6): 1703-1716, 2023.
Article in English | WPRIM | ID: wpr-1010631

ABSTRACT

Understanding the fundamental processes of human brain development and diseases is of great importance for our health. However, existing research models such as non-human primate and mouse models remain limited due to their developmental discrepancies compared with humans. Over the past years, an emerging model, the "brain organoid" integrated from human pluripotent stem cells, has been developed to mimic developmental processes of the human brain and disease-associated phenotypes to some extent, making it possible to better understand the complex structures and functions of the human brain. In this review, we summarize recent advances in brain organoid technologies and their applications in brain development and diseases, including neurodevelopmental, neurodegenerative, psychiatric diseases, and brain tumors. Finally, we also discuss current limitations and the potential of brain organoids.


Subject(s)
Animals , Mice , Humans , Induced Pluripotent Stem Cells , Brain/pathology , Disease Models, Animal , Neurodegenerative Diseases/pathology , Organoids/pathology
3.
Neuroscience Bulletin ; (6): 99-112, 2023.
Article in English | WPRIM | ID: wpr-971538

ABSTRACT

Neurodegenerative diseases (NDs) have become a significant threat to an aging human society. Numerous studies have been conducted in the past decades to clarify their pathologic mechanisms and search for reliable biomarkers. Magnetic resonance imaging (MRI) is a powerful tool for investigating structural and functional brain alterations in NDs. With the advantages of being non-invasive and non-radioactive, it has been frequently used in both animal research and large-scale clinical investigations. MRI may serve as a bridge connecting micro- and macro-level analysis and promoting bench-to-bed translational research. Nevertheless, due to the abundance and complexity of MRI techniques, exploiting their potential is not always straightforward. This review aims to briefly introduce research progress in clinical imaging studies and discuss possible strategies for applying MRI in translational ND research.


Subject(s)
Animals , Humans , Neurodegenerative Diseases/pathology , Translational Research, Biomedical , Magnetic Resonance Imaging/methods , Brain/pathology , Head/pathology
4.
Braz. J. Pharm. Sci. (Online) ; 59: e22381, 2023. tab, graf
Article in English | LILACS | ID: biblio-1439529

ABSTRACT

Abstract Acai (Euterpe oleracea Mart.) and guarana (Paullinia cupana Kunth) are native species from the Amazon Forest that in folk medicine are used to treat several diseases due to their anti-inflammatory and antioxidant properties. This review brings together findings from different studies on the potential neuroprotective effects of acai and guarana, highlighting the importance of the conservation and sustainable exploitation of the Amazon Forest. A bibliographic survey in the PubMed database retrieved indexed articles written in English that focused on the effects of acai and guarana in in vitro and in vivo models of neurodegenerative diseases. In general, treatment with either acai or guarana decreased neuroinflammation, increased antioxidant responses, ameliorated depression, and protected cells from neurotoxicity mediated by aggregated proteins. The results from these studies suggest that flavonoids, anthocyanins, and carotenoids found in both acai and guarana have therapeutic potential not only for neurodegenerative diseases, but also for depressive disorders. In addition, acai and guarana show beneficial effects in slowing down the physiological aging process. However, toxicity and efficacy studies are still needed to guide the formulation of herbal medicines from acai and guarana.


Subject(s)
Amazonian Ecosystem , Paullinia/adverse effects , Euterpe/adverse effects , Fruit/classification , In Vitro Techniques/methods , Neuroprotective Agents/classification , Neurodegenerative Diseases/pathology , Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology
5.
Arq. neuropsiquiatr ; 80(2): 180-191, Feb. 2022. tab, graf
Article in English | LILACS | ID: biblio-1364366

ABSTRACT

ABSTRACT Structural imaging of the brain is the most widely used diagnostic tool for investigating neurodegenerative diseases. More advanced structural imaging techniques have been applied to early or prodromic phases, but they are expensive and not widely available. Therefore, it is highly desirable to search for noninvasive, easily accessible, low-cost clinical biomarkers suitable for large-scale population screening, in order to focus on making diagnoses at the earliest stages of the disease. In this scenario, imaging studies focusing on the structures of the retina have increasingly been used for evaluating neurodegenerative diseases. The retina shares embryological, histological, biochemical, microvascular and neurotransmitter similarities with the cerebral cortex, thus making it a uniquely promising biomarker for neurodegenerative diseases. Optical coherence tomography is a modern noninvasive imaging technique that provides high-resolution two-dimensional cross-sectional images and quantitative reproducible three-dimensional volumetric measurements of the optic nerve head and retina. This technology is widely used in ophthalmology practice for diagnosing and following up several eye diseases, such as glaucoma, diabetic retinopathy and age-related macular degeneration. Its clinical impact on neurodegenerative diseases has raised enormous interest over recent years, as several clinical studies have demonstrated that these diseases give rise to reduced thickness of the inner retinal nerve fiber layer, mainly composed of retinal ganglion cells and their axons. In this review, we aimed to address the clinical utility of optical coherence tomography for diagnosing and evaluating different neurodegenerative diseases, to show the potential of this noninvasive and easily accessible method.


RESUMO A avaliação estrutural do cérebro, feita por meio dos exames de neuroimagem, é a forma mais utilizada de ferramenta diagnóstica e de acompanhamento das doenças neurodegenerativas. Técnicas de imagem mais sofisticadas podem ser necessárias especialmente nas fases mais precoces, antes mesmo do surgimento de quaisquer sintomas, porém costumam ser caras e pouco acessíveis. Sendo assim, é de fundamental importância a busca de biomarcadores não invasivos, de fácil acesso e baixo custo, que possam ser utilizados para rastreio populacional e diagnóstico mais precoce. Nesse cenário, o número de estudos com ênfase em técnicas de imagem para avaliação estrutural da retina em pacientes com doenças neurodegenerativas tem aumentado nos últimos anos. A retina apresenta similaridade embriológica, histológica, bioquímica, microvascular e neurotransmissora com o córtex cerebral, tornando-se assim um biomarcador único e promissor nas doenças neurodegenerativas. A tomografia de coerência óptica é uma moderna técnica de imagem não invasiva que gera imagens seccionais bidimensionais de alta resolução e medidas volumétricas tridimensionais reprodutivas do disco óptico e da mácula. Essa tecnologia é amplamente utilizada na prática oftalmológica para o diagnóstico e o seguimento de diversas doenças oculares, como glaucoma, retinopatia diabética e degeneração macular relacionada à idade. A redução da espessura da camada de fibras nervosas da retina e das camadas de células ganglionares em pacientes com doenças neurodegenerativas foi demonstrada em diversos estudos clínicos nos últimos anos. Nesta revisão, abordamos as principais aplicações clínicas da tomografia de coerência óptica nas doenças neurodegenerativas e discutimos o seu papel como potencial biomarcador nessas afecções.


Subject(s)
Humans , Neurodegenerative Diseases/pathology , Neurodegenerative Diseases/diagnostic imaging , Tomography, Optical Coherence/methods , Retina/pathology , Retina/diagnostic imaging
6.
Arq. neuropsiquiatr ; 75(8): 570-579, Aug. 2017. tab, graf
Article in English | LILACS | ID: biblio-888318

ABSTRACT

ABSTRACT Corticobasal degeneration (CBD) was originally described as a distinct clinicopathological entity in 1967. Since then, different phenotypic presentations have emerged as possible manifestations of CBD histopathological findings. In addition, pathophysiological findings and the molecular basis have been delineated and several aspects of its cognitive manifestations have been clarified. Thus, not only the spectrum of what is currently designated as CBD has expanded, but overlap with other degenerative and even secondary disorders has made clinical diagnostic certainty even more challenging in the absence of specific and readily-available markers. Cognitive deficits in CBD are now recognized as a frequent initial presentation and may appear up to eight years before the motor symptoms, depending on the phenotypic variant. Characteristic cognitive features of CBD involve language deficits, visuospatial and executive dysfunctions, apraxia, and behavioral disorders. Semantic and episodic memories are usually preserved, while language is often impaired in the early stages.


RESUMO A degeneração corticobasal (DCB) foi originalmente descrita como uma entidade clínico-patológica distinta em 1967. Desde então, nossa compreensão sobre DCB evoluiu substancialmente. Diferentes apresentações fenotípicas emergiram refletindo possíveis manifestações das anormalidades histopatológicos da DCB. Adicionalmente, dados fisiopatológicos e moleculares foram delineados e aspectos das manifestações cognitivas foram explorados. Assim, não só o espectro do que é atualmente designado DCB foi expandido, mas a sobreposição com outras doenças degenerativas e até mesmo secundárias tornaram o diagnóstico clínico ainda mais desafiador na ausência de marcadores específicos e prontamente disponíveis. Déficits cognitivos na DCB são agora reconhecidos frequentemente como apresentações iniciais e podem surgir até 8 anos antes dos sintomas motores, dependendo da variante fenotípica. O quadro cognitivo envolve característicamente déficits de linguagem, disfunção visuoespacial e executiva, apraxia, e distúrbios comportamentais. Anormalidades da linguagem são frequentemente descritas nos estágios iniciais da DCB.


Subject(s)
Humans , Basal Ganglia/pathology , Cerebral Cortex/pathology , Neurodegenerative Diseases/pathology , Dementia/pathology , Cognitive Dysfunction/pathology , Aphasia/pathology , Psychiatric Status Rating Scales , Atrophy/pathology , Speech/physiology , Neurodegenerative Diseases/diagnosis , Neurodegenerative Diseases/psychology , Dementia/diagnosis , Diagnosis, Differential , Cognitive Dysfunction/diagnosis , Language , Neuropsychological Tests
7.
Medicina (B.Aires) ; 77(4): 314-320, ago. 2017. ilus
Article in Spanish | LILACS | ID: biblio-894485

ABSTRACT

La autofagia es un proceso de reciclado de partes de la célula. Como se describe en esta revisión, ocurre naturalmente preservando a las células de la acumulación de toxinas, moléculas y organelas dañadas y además permite los procesos de desarrollo y diferenciación de los tejidos. En el transcurso de la autofagia, el procesamiento de los sustratos a reciclar genera ATP, lo que constituye una fuente alternativa de energía en situaciones de estrés. En este sentido, bajo condiciones hostiles como hipoxia o falta de nutrientes, el proceso puede dispararse de modo exacerbado llevando a la muerte celular. Algunas alteraciones en su funcionamiento pueden involucrar el desarrollo de diversas patologías, tales como el daño hepático, el cáncer y las enfermedades neurodegenerativas.


Autophagy is a process of recycling parts of the cell. As described in this review, it occurs naturally in order to preserve cells from the accumulation of toxins, damaged molecules and organelles, and to allow processes of tissue development and differentiation. In the course of autophagy, the processing of the substrates to be recycled generates ATP, thus providing an alternative source of energy in stress situations. In this sense, under hostile conditions such as hypoxia or lack of nutrients, the autophagy process can be exacerbated leading to cell death. Some alterations in its functioning may involve the development of various pathologies, including liver damage, cancer and neurodegenerative diseases.


Subject(s)
Humans , Autophagy/physiology , Cell Differentiation/physiology , Cell Survival/physiology , Neurodegenerative Diseases/pathology , Energy Metabolism/physiology , Neoplasms/pathology , Cell Hypoxia , Adenosine Triphosphate/metabolism , Neurodegenerative Diseases/physiopathology , Neoplasms/physiopathology
8.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 39(2): 180-182, Apr.-June 2017. tab
Article in English | LILACS | ID: biblio-844188

ABSTRACT

Objectives: To describe the frequency of brain tissue donation for research purposes by families of individuals that committed suicide. Methods: All requests for brain tissue donation to a brain biorepository made to the families of individuals aged 18-60 years who had committed suicide between March 2014 and February 2016 were included. Cases presenting with brain damage due to acute trauma were excluded. Results: Fifty-six cases of suicide were reported. Of these, 24 fulfilled the exclusion criteria, and 11 others were excluded because no next of kin was found to provide informed consent. Of the 21 remaining cases, brain tissue donation was authorized in nine (tissue fragments in seven and the entire organ in two). Conclusions: Donation of brain tissue from suicide cases for research purposes is feasible. The acceptance rate of 42.8% in our sample is in accordance with international data on such donations, and similar to rates reported for neurodegenerative diseases.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Young Adult , Suicide/statistics & numerical data , Tissue Donors/statistics & numerical data , Brain/anatomy & histology , Biomedical Research/statistics & numerical data , Autopsy/statistics & numerical data , Tissue Banks/statistics & numerical data , Brazil , Neurodegenerative Diseases/pathology , Informed Consent/statistics & numerical data
9.
Arq. neuropsiquiatr ; 73(7): 569-577, 07/2015. tab, graf
Article in English | LILACS | ID: lil-752377

ABSTRACT

With the increase in life expectancy in Brazil, concerns have grown about the most prevalent diseases in elderly people. Among these diseases are neurodegenerative diseases, such as Alzheimer’s and Parkinson’s diseases. Protein deposits related to the development of these diseases can pre-date the symptomatic phases by years. The tau protein is particularly interesting: it might be found in the brainstem and olfactory bulb long before it reaches the limbic cortex, at which point symptoms occur. Of the 14 brains collected in this study, the tau protein was found in the brainstems of 10 (71.42%) and in olfactory bulbs of 3 out 11. Of the 7 individuals who had a final diagnosis of Alzheimer’s disease (AD), 6 presented tau deposits in some region of the brainstem. Our data support the idea of the presence of tau protein in the brainstem and olfactory bulb in the earliest stages of AD.


Com o aumento da expectativa de vida no Brasil e no mundo, crescem as preocupações com as doenças mais prevalentes entre os idosos, dentre elas as doenças neurodegenerativas (DN) como a doença de Alzheimer (DA) e a doença de Parkinson (DP). Sabe-se que os depósitos proteicos relacionados com o desenvolvimento destas doenças podem preceder a fase sintomática em anos. A proteína tau é de particular interesse, uma vez que parece ser encontrada no tronco encefálico e bulbo olfatório muito antes de atingir o córtex límbico, quando ocorrem os primeiros sintomas. Dos 14 encéfalos coletados neste estudo, a proteína tau foi encontrada, no tronco encefálico, em 10 (71,42%) e no bulbo olfatório em 3 de 11. Dos 7 indivíduos que tiveram diagnóstico final de DA, todos apresentavam depósitos de tau em alguma região do tronco encefálico. Nossos dados estão de acordo com a literatura mais recente, que tem confirmado a presença de proteína tau no tronco encefálico e bulbo olfatório nos estágios mais precoces da DA.


Subject(s)
Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Brain Stem/pathology , Neurodegenerative Diseases/pathology , Olfactory Bulb/pathology , Age Factors , Amyloid beta-Peptides/analysis , Brain Stem/chemistry , Immunohistochemistry , Olfaction Disorders/pathology , Olfactory Bulb/chemistry , Phosphorylation , Reference Values , alpha-Synuclein/analysis , tau Proteins/analysis
10.
Salud pública Méx ; 57(1): 4-13, ene.-feb. 2015. tab
Article in English | LILACS | ID: lil-736456

ABSTRACT

Objective. To describe food expenditure and consumption of foods prepared away from home among Mexican adults. Materials and methods. Data were from 45 241 adult participants in the National Health and Nutrition Survey 2006, a nationally-representative, cross-sectional survey of Mexican households. Descriptive statistics and multivariable linear and logistic regression were used to assess the relationship between location of residence, educational attainment, socioeconomic status and the following: 1) expenditure on all food and at restaurants, and 2) frequency of consumption of comida corrida or restaurant food and street food. Results. Food expenditure and consumption of food prepared away from home were positively associated with socioeconomic status, educational attainment, and urban vs. rural residence (p<0.001 for all relationships in bivariate analyses). Conclusions. Consumption of food prepared outside home may be an important part of the diet among urban Mexican adults and those with high socioeconomic status and educational attainment.


Objetivo. Describir los gastos en alimentos y el consumo de alimentos preparados fuera de casa en población mexicana. Material y métodos. Los datos fueron de 45 241 adultos mexicanos en la Encuesta Nacional de Salud y Nutrición de 2006, representativa al nivel nacional. Se utilizaron estadísticas descriptivas y regresión linear y logística para estimar la relación entre el lugar de residencia, el nivel educativo y el nivel socioeconómico, con el gasto en todos los alimentos y en restaurantes, y con la frecuencia de consumo de comida corrida, en restaurantes y de la calle. Resultados. El gasto en alimentos y el consumo de alimentos preparados se asociaron positivamente con el nivel socioeconómico, el nivel educativo y la residencia rural (p<0,001 para todas las relaciones). Conclusiones. El consumo de alimentos preparados puede ser una parte importante de la dieta de los adultos urbanos y de aquéllos con altos niveles socioeconómicos y educativos.


Subject(s)
Animals , Cricetinae , Female , Humans , Male , Mice , G Protein-Coupled Inwardly-Rectifying Potassium Channels/chemistry , Neurodegenerative Diseases/pathology , Spinal Cord/metabolism , Tyrosine/chemistry , DNA , Anisomycin/chemistry , Antibodies/chemistry , Behavior , Blotting, Western , CHO Cells , Cell Line , Cell Line, Tumor , Dose-Response Relationship, Drug , Electrophysiology , Enzyme-Linked Immunosorbent Assay , G Protein-Coupled Inwardly-Rectifying Potassium Channels/physiology , GTP-Binding Proteins/metabolism , Heart Atria/metabolism , Heart Ventricles/cytology , Heart Ventricles/pathology , Immunoblotting , Immunohistochemistry , Inflammation , Microscopy, Confocal , Microscopy, Fluorescence , Muscle Cells/metabolism , Neurons/metabolism , Phosphorylation , Plasmids/metabolism , Protein Structure, Tertiary , Sciatic Nerve/metabolism , Spinal Cord/pathology , Stress, Physiological , Xenopus laevis
11.
Article in English | LILACS | ID: lil-691402

ABSTRACT

Neurodegenerative diseases are pathological conditions that have an insidious onset and chronic progression. Different models have been established to study these diseases in order to understand their underlying mechanisms and to investigate new therapeutic strategies. Although various in vivo models are currently in use, in vitro models might provide important insights about the pathogenesis of these disorders and represent an interesting approach for the screening of potential pharmacological agents. In the present review, we discuss various in vitro and ex vivo models of neurodegenerative disorders in mammalian cells and tissues.


Subject(s)
Animals , Mice , Rats , Alzheimer Disease/pathology , Amyotrophic Lateral Sclerosis/pathology , Culture Techniques/methods , Huntington Disease/pathology , Parkinson Disease/pathology , Alzheimer Disease/etiology , Amyotrophic Lateral Sclerosis/etiology , Astrocytes , Cells, Cultured , Disease Models, Animal , Huntington Disease/etiology , Microglia , Neurodegenerative Diseases/etiology , Neurodegenerative Diseases/pathology , Parkinson Disease/etiology
12.
Arq. neuropsiquiatr ; 70(8): 574-577, Aug. 2012. ilus, tab
Article in English | LILACS | ID: lil-645366

ABSTRACT

OBJECTIVE: To determine if the presence of oligoclonal bands (OB) at early stages of multiple sclerosis was associated with higher brain atrophy, when compared with patients without OB. METHODS: Relapsing-remitting multiple sclerosis (RRMS) patients with less than two years of disease onset and OB detection in cerebrospinal fluid (CSF) were included. SIENAX was used for total brain volume (TBV), gray matter volume (GMV), and white matter volume (WMV). RESULTS: Forty patients were included, 29 had positive IgG-OB. No differences were found between positive and negative patients in gender, expanded disability status scale (EDSS), treatment received, and T2/T1 lesion load. TBV in positive IgG-OB patients was 1.5 mm³ x 10(6) compared with 1.64 mm³ x 10(6) in the negative ones (p=0.02). GMV was 0.51 mm³ x 10(6) in positive IgG-OB compared with 0.62 mm³ x 10(6) in negative ones (p=0.002). No differences in WMV (p=0.09) were seen. CONCLUSIONS: IgG-OB in the CSF was related to neurodegeneration magnetic resonance (MR) markers in early RRMS.


OBJETIVO: Evaluar si la presencia de bandas oligoclonales (BO) en líquido cefalorraquídeo (LCR) de pacientes con esclerosis múltiple recaídaremisión (EMRR) se asociaba con mayor atrofia cerebral al inicio de la enfermedad. MÉTODOS: Pacientes con EMRR con menos que dos años del inicio de la enfermedad y en quiénes se realizó la búsqueda de IgG-BO en LCR fueron incluidos. SIENAX fue usado para la medición del volumen cerebral total (VCT), volumen de substancia gris (VSG) y volumen de sustancia blanca (VSB). RESULTADOS: Cuarenta pacientes fueron incluidos, 29 tenían IgG-BO positivo. No fueron encontradas diferencias entre pacientes positivos y negativos en: género, expanded disability status scale (EDSS), tratamiento recibido y carga lesional en resonancia magnética. El VCT en pacientes IgG-BO positivos fue de 1,5 mm³ x 10(6) versus 1,64 mm³ x 10(6) en BO negativo (p=0,02). El VSG fue 0,51 mm³ x 10(6) BO positivo versus 0,62 mm³ x 10(6) BO negativo (p=0,002). No fueron encontradas diferencias en VSB (p=0,09). CONCLUSIONES: La presencia de IgG-BO en el LCR se asoció con signos de neurodegeneración temprana en este estudio.


Subject(s)
Adult , Female , Humans , Male , Brain Diseases/cerebrospinal fluid , Brain/pathology , Multiple Sclerosis, Relapsing-Remitting/cerebrospinal fluid , Neurodegenerative Diseases/cerebrospinal fluid , Oligoclonal Bands/cerebrospinal fluid , Atrophy/cerebrospinal fluid , Atrophy/pathology , Biomarkers/cerebrospinal fluid , Brain Diseases/pathology , Cross-Sectional Studies , Diagnosis, Differential , Disability Evaluation , Disease Progression , Magnetic Resonance Imaging , Multiple Sclerosis, Relapsing-Remitting/pathology , Neurodegenerative Diseases/pathology
13.
Gac. méd. Caracas ; 119(4): 320-328, oct.-dic. 2011. ilus
Article in Spanish | LILACS | ID: lil-701634

ABSTRACT

El síndrome de Ross fue descrito en 1958 como una afección degenerativa del sistema nervioso autónomo definido por la tríada de anhidrosis generalizada, disminución de los reflejos tendinosos y pupila tónica. Desde su descripción inicial se han descrito cerca de cuarenta casos. Comunicamos tres pacientes con variantes de interés que incluyen la presencia de espasmos cíclicos espontáneos del esfínter de iris, el desarrollo conjunto de síndrome de Holmes-Adie en un lado y síndrome Horner posganglionar en el otro, trastornos del desarrollo piloso en el lado de la anhidrosis, alteraciones de la motilidad intestinal, lengua sin papilas gustativas y disfunción sexual.


Ross Syndrome was described in 1958 as a degenerative condition of the autonomic nervous system defined by a triad of generalized anhidrosis, reduction of tendon reflexes and tonic pupil. Since its initial description about 40 cases have been described. We communicate three cases with variants of interest involving the presence of the simultaneous development of syndrome of Holmes-Adie on one side and Horner syndrome in the other, disorders of pilous follicle development on the side of anhidrosis, spontaneous disturbances of intestinal motility, tonque without papillae and sexual dysfunction.


Subject(s)
Humans , Male , Adult , Female , Middle Aged , Headache/diagnosis , Nerve Degeneration/pathology , Neurodegenerative Diseases/pathology , Iris Diseases/pathology , Hyperhidrosis/pathology , Hypesthesia/diagnosis , Oculomotor Nerve/anatomy & histology , Tonic Pupil/diagnosis , Horner Syndrome/pathology , Miller Fisher Syndrome/physiopathology , Visual Acuity/physiology , Anisocoria/physiopathology , Biopsy/methods , Blepharoptosis/etiology , Mydriasis/physiopathology
14.
Indian J Biochem Biophys ; 2011 Apr; 48(2): 73-81
Article in English | IMSEAR | ID: sea-135303

ABSTRACT

Peroxisome proliferator-activated receptors (PPARs) belong to the nuclear receptor superfamily. PPAR-alpha is involved in wound healing, stimulation of lipid and folic acid catabolism, inflammation control, inhibition of ureagenesis and peroxisome proliferation. The PPAR/ is involved wound healing, cell proliferation, embryo implantation, adipocyte differentiation, myelination alteration and apoptosis. The PPAR is involved in fat, lipid and calorie utilization, sugar control, inflammation control and macrophage (MQ) matutation. Homocysteine (Hcy) binds to nuclear peroxisome proliferator activated receptor. Increase in PPAR expression decreases the level of nitrotyrosine and increases endothelial nitric oxide concentration, decreases metalloproteinase activity and expression as well as elastinolysis and reverses Hcy-mediated vascular dysfunction. The PPAR initially recognized as a regulator of adipocyte development has become a potential therapeutic target for the treatment of diverse disorders. In addition, the activation of PPAR receptor ameliorates neurodegenerative disease. This review focuses on the recent knowledge of PPAR in neuroprotection and deals with the mechanism of neuroprotection of central nervous system disorder by PPAR.


Subject(s)
Animals , Brain Ischemia/metabolism , Brain Ischemia/pathology , Brain Ischemia/therapy , Cell Death , Central Nervous System/cytology , Central Nervous System/metabolism , Central Nervous System/pathology , Cytoprotection , Humans , Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/pathology , Neurodegenerative Diseases/therapy , Neurons/cytology , Neurons/pathology , Neuroprotective Agents/metabolism , PPAR gamma/metabolism
15.
Arq. bras. med. vet. zootec ; 62(1): 92-99, Feb. 2010. ilus
Article in Portuguese | LILACS | ID: lil-543074

ABSTRACT

Foram utilizados 55 ratos machos da espécie Rattus novergicus, variedade Wistar, com o objetivo de propor um modelo experimental de trauma medular produzido por aparelho estereotáxico modificado, capaz de reproduzir clinicamente lesões medulares padronizadas. Após realização de laminectomia dorsal de T13, utilizou-se peso compressivo de 50,5g (25 animais - grupo I) ou 70,5g (30 animais - grupo II), durante cinco minutos, comprimindo a medula espinhal. Os animais foram assistidos durante oito dias, por meio de testes comportamentais para avaliar a sensibilidade dolorosa, a capacidade motora, o posicionamento tátil e proprioceptivo e a capacidade de manter-se em plano inclinado. No grupo I, observaram-se déficits neurológicos moderados e transitórios, que variaram entre os animais. No grupo II, foi possível obter um trauma padronizado, caracterizado por paraplegia bilateral e simétrica dos membros posteriores, perda de propriocepção e da sensibilidade dolorosa de todos os animais. A utilização do aparelho estereotáxico desenvolvido permite reproduzir clinicamente trauma medular padronizado em ratos, de maneira simples, econômica e satisfatória, o que poderá proporcionar avanços nas investigações terapêuticas, abrangendo doenças neurodegenerativas, como é o caso do trauma medular agudo.


Fifty-five male rats (Rattus novergicus), Wistar variety, were used with the purpose of suggesting an experimental model of spinal cord trauma performed by using a modified stereotaxic equipment capable to reproduce clinically (standardized) pattern spinal cord injury. After dorsal laminectomy of T13, a compression was performed with 50.5g (25 animals - group I) or 70.5g (30 animals - group II) during five minutes on spinal cord. The animals were assisted during eight days by behavioral tests to evaluate painful sensibility, motor capacity, proprioceptive and tactil placing, and stability on inclined plan. In the group I, moderate and transitory neurological deficits were observed, that varied among the animals. In the group II, a standardized trauma was obtained, characterized by bilateral and symmetrical paraplegia of hindlimbs, loss of proprioception, and painful sensibility in all the animals. The use of developed stereotaxic equipment allowed to reproduce pattern spinal cord injury in rats, by a simply, economic, and satisfactory way. This can provide progresses in the therapeutic investigations embracing neurodegenerative diseases, like spinal cord injury.


Subject(s)
Animals , Male , Rats , Spinal Cord Injuries , Stereotaxic Techniques/instrumentation , Neurodegenerative Diseases/pathology , Rats , Spinal Cord
16.
Rev. méd. Chile ; 137(11): 1482-1487, nov. 2009. tab, ilus
Article in Spanish | LILACS | ID: lil-537013

ABSTRACT

Posterior cortical atrophy (PCA) is a neurodegenerative syndrome, usually due to Alzheimer's disease. The first symptoms are progressive impairment of visuo spatial (Balint's and Gertsmann's syndromes) or visuo perceptive (visual agnosia, alexia) function. Episodic memory and executive function are spared until later stages. We report two males aged 51 and 55years and three females aged 50, 54 and 56 years, with posterior cortical atrophy. Ophthalmologic study was normal in all. Presenting signs and symptoms were visual ataxia, simultagnosia, agraphia, acalculia, spatial disorientation and unilateral neglect (Balint's and Gerstmann's syndromes). Apperceptive visual agnosia, aphasia, apraxia and alexia were also observed. One female had cortical blindness. Structural images were inconclusive, but PET scan and SPECT disclosed functional impairments in occipitotemporal or occipitoparietal areas.


Subject(s)
Female , Humans , Male , Middle Aged , Cerebral Cortex/pathology , Cognition Disorders/pathology , Neurodegenerative Diseases/pathology , Atrophy/pathology , Occipital Lobe/pathology , Ocular Motility Disorders/classification , Ocular Motility Disorders/pathology , Visual Perception/physiology
17.
Arch. venez. farmacol. ter ; 27(1): 40-57, 2008. ilus
Article in Spanish | LILACS | ID: lil-517087

ABSTRACT

La interacción entre el ambiente y la genética durante la evolución de la especie humana ha predispuesto al padecimiento de muchas enfermedades crónico-degenerativas comunes de nuestra sociedad occidentalizada. El genotipo “Thrifty”, producto de la adaptación del hombre paleolítico y neolítico al medio, se caracteriza por hiperinsulinemia sin inhibición de la gluconeogenesis, que, aunada al estilo de vida condiciona el desarrollo de enfermedades cardiovasculares (ECV). Múltiples hipótesis intentan explicar la elevada morbimortalidad por ECV en los diferentes grupos étnicos. Por ejemplo, las poblaciones afro-americanas presentan isoformas de proteínas desacoplantes relacionados con bajo gasto energético basal y metabolismo oxidativo de los ácidos grasos (AG) disminuido, así como una concentración elevada de Lipoproteína(a) y alta sensibilidad a la sal. La población asiática posee numerosos factores de riesgos cardiovasculares contrarrestados en parte por una dieta rica en PUFA´s ω-3. No obstante, los indio-asiáticos aún teniendo una dieta baja en AG saturados, presentan alta prevalencia de ECV, lo que se ha tratado de explicar por la expresión de un genotipo “Thrifty”. Las poblaciones hispánicas caracterizadas por su origen multirracial presentan alta incidencia de obesidad y diabetes relacionada a leptinorresistencia e insulinorresistencia, con hiperinsulinemia compensadora –de duración variable- que aparentemente precede a la hipertensión arterial esencial. En poblaciones indígenas norteamericanas como los Pima se observa la prevalencia más alta de diabetes a nivel mundial, sugiriéndose una conexión con el gen de la PPP1R3, niveles de TNF-α elevados e IL-6, entre otros.


Subject(s)
Humans , Male , Female , Cardiovascular Diseases , Ethnicity , Neurodegenerative Diseases/pathology , Genotype , Phenotype , Risk Factors
18.
Journal of Korean Medical Science ; : 908-911, 2007.
Article in English | WPRIM | ID: wpr-176590

ABSTRACT

Marchiafava-Bignami disease (MBD) is a rare alcohol-related disorder that results in progressive demyelination and necrosis of the corpus callosum. The process may extend to the optic chiasm and tracts, cerebellar peduncle, subcortical resion, neighboring white matter, and rarely, cortical gray matter. We report a case of MBD in which fluid-attenuated inversion recovery and diffusion magnetic resonance imaging studies revealed symmetrical hyperintense lesions in the cerebral cortex in addition to the callosal lesions.


Subject(s)
Humans , Male , Middle Aged , Alcoholism/complications , Brain/pathology , Cerebral Cortex/pathology , Corpus Callosum/pathology , Demyelinating Diseases/pathology , Diffusion Magnetic Resonance Imaging/methods , Marchiafava-Bignami Disease/diagnosis , Necrosis/pathology , Neurodegenerative Diseases/pathology , Optic Chiasm/pathology , Seizures , Time Factors , Treatment Outcome , Vitamin B Complex/therapeutic use
20.
Biol. Res ; 39(1): 15-23, 2006. ilus, tab
Article in English | LILACS | ID: lil-430694

ABSTRACT

Aceruloplasminemia is an autosomal recessive neurodegenerative disease characterized by iron accumulation in the brain as well as visceral organs. It is a loss-of-function disorder caused by mutations in the ceruloplasmin gene. Clinically, this disease consists of the triad of adult-onset neurological disease, retinal degeneration and diabetes mellitus. Massive iron accumulation and extensive loss of neurons are observed in the basal ganglia. The elevated iron concentration is associated with increased lipid peroxidation in the brains of aceruloplasminemia patients. Enlarged or deformed astrocytes and spheroid-like globular structures are characteristic neuropathological findings in aceruloplasminemia. Moreover, deformed astrocytes and globular structures react positively to anti-4-hydroxynonenal antibody, suggesting that increased oxidative stress is involved in neuronal cell death in aceruloplasminemia brain. More than 30 aceruloplasminemia-causing mutations in the ceruloplasmin gene have been identified. We examined the biosynthesis of two missense ceruloplasmin proteins that result from a Japanese P177R mutation and a Dutch G631R mutation, using Chinese hamster ovary cell expression system. The P177R mutant protein is retained in the endoplasmic reticulum. The G631R mutant protein, predicted to alter the interactions at a single type I copper-binding site, prevented incorporation of copper into apoceruloplasmin and resulted in the synthesis and secretion only of apoceruloplasmin. Molecular analysis of missense mutations showed different structure-function relationships in ceruloplasmin protein. The investigation of mutant ceruloplasmin reveals new insights into molecular pathogenesis of aceruloplasminemia as well as biosynthesis, trafficking, and function of ceruloplasmin.


Subject(s)
Animals , Cricetinae , Humans , Ceruloplasmin/genetics , Iron Metabolism Disorders/complications , Mutation, Missense/genetics , Neurodegenerative Diseases/etiology , Amino Acid Sequence , Astrocytes/pathology , Brain/metabolism , Brain/pathology , Ceruloplasmin/biosynthesis , Immunohistochemistry , Iron Metabolism Disorders/genetics , Iron Metabolism Disorders/pathology , Lipid Peroxidation , Molecular Sequence Data , Neurodegenerative Diseases/genetics , Neurodegenerative Diseases/pathology
SELECTION OF CITATIONS
SEARCH DETAIL